Pure Global AI
NCT06290947Completed

BFR Walking for Insulin and Aerobic Improvement in Type 2 Diabetes

Evaluating the Impact of Blood-Flow Restriction Walk Training on Insulin Sensitivity and Aerobic Capacity in Individuals With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
Arab American University (Palestine)ClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Type 2 Diabetes Mellitus
Drug/Device/Intervention
BFR Cuffs for Intervention Group
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Arab American University (Palestine)
Location
Jenin, Palestinian
Timeline & enrollment
Phase
N/A
Start date
Mar 06, 2022
End date
Jan 08, 2024
Enrollment
60 participants
Primary outcome

Improvement in Insulin Sensitivity,Improvement in Aerobic Capacity

Summary

This clinical trial examines the impact of Blood-Flow Restriction Walk Training (BFRw) on
 insulin sensitivity and aerobic capacity in individuals with Type 2 Diabetes (T2D).
 
 The primary objectives of the study are to determine: If Blood-Flow Restriction Walk Training
 (BFRw) can improve insulin sensitivity in individuals with Type 2 Diabetes (T2D).
 
 Whether Blood-Flow Restriction Walk Training (BFRw) enhances aerobic capacity in individuals
 with Type 2 Diabetes (T2D).
 
 Participants in the study are divided into two groups. One group undergoes Blood-Flow
 Restriction Walk Training (BFRw), and the other serves as a control. Both groups attend three
 treadmill walking sessions weekly for eight weeks. The BFRw group has a restriction cuff
 placed around both thighs during their sessions, while the control group participates in the
 walking sessions without any blood flow restriction.
 
 Hemoglobin A1c (HbA1c) levels and maximal oxygen consumption (VO2 max) are monitored as
 indicators of insulin sensitivity and aerobic capacity, respectively.

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06290947
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06290947 through Pure Global AI's free database. This phase not specified trial is sponsored by Arab American University (Palestine) and is currently Completed. The study focuses on Type 2 Diabetes Mellitus. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.